Kivu Bioscience Funding: $92M Raised, Series A (2024)
Kivu Bioscience has raised $92M in total funding. Latest round: Series A. Backed by Novo Holdings.
Kivu Bioscience funding overview
Kivu Bioscience has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for Kivu Bioscience runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings.
Kivu Bioscience at a glance
Total raised
$92M
Latest round
Series A
Latest round date
October 2024
Notable investors
Novo Holdings
Frequently asked about Kivu Bioscience funding
How much has Kivu Bioscience raised?
Kivu Bioscience has raised $92M in total disclosed funding across the rounds on record.
Who has invested in Kivu Bioscience?
Novo Holdings are named among the investors backing Kivu Bioscience.
What was the latest Kivu Bioscience funding round?
The most recent disclosed round is a Series A, announced in October 2024.
Where is Kivu Bioscience based?
No headquarters location is disclosed for Kivu Bioscience.
When did Kivu Bioscience last raise?
The last disclosed Kivu Bioscience round closed in October 2024 at Series A.
We update the Kivu Bioscience record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.
